Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Taro Pharmaceutical Industries Ltd. TARO
$30.66
-$1.39 (-4.55%)
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
1174894596.00000000
-
week52high
40.16
-
week52low
22.89
-
Revenue
561347000
-
P/E TTM
27
-
Beta
0.70449800
-
EPS
1.74000000
-
Last Dividend
12.81000000
-
Next Earnings Date
24 мая 2023 г. в 20:00
Описание компании
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 15 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 31 янв 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 18 янв 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 28 июл 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 02 июн 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 25 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | D | 0 | 712500 | 18 янв 2011 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | A | 15210433 | 712500 | 18 янв 2011 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | A | 15922933 | 712500 | 18 янв 2011 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | A | 14497933 | 5159765 | 04 ноя 2010 г. |
| FRANKLIN RESOURCES INC | D | 0 | 5159765 | 01 ноя 2010 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | A | 9338168 | 2333922 | 01 окт 2010 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | D | 0 | 75000 | 27 сент 2010 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | D | 75000 | 3712500 | 24 сент 2010 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | A | 13500000 | 3712500 | 24 сент 2010 г. |
| SUN PHARMACEUTICAL INDUSTRIES LTD | D | 2333922 | 2405937 | 20 сент 2010 г. |
Новостная лента
Taro Pharmaceutical: Stagnating Growth At 1.6% Trailing Earnings Yield, Rate Hold
Seeking Alpha
24 февр 2023 г. в 00:18
Taro Pharmaceutical's quarterly numbers came in with very thin growth at the operating and bottom-lines given the impact from settlement charges. Price erosion in its U.S. generics business continues to be a headwind.
Francisco Garcia Parames' Cobas Funds 4th-Quater Letter
GuruFocus
22 февр 2023 г. в 18:01
Dear Investor:
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates
Zacks Investment Research
24 янв 2023 г. в 20:19
Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Taro to Release Third Quarter Results on January 24, 2023
Business Wire
19 янв 2023 г. в 17:02
HAWTHORNE, N.Y.--( BUSINESS WIRE )--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after the close of market on Tuesday, January 24, 2023.
Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates
Zacks Investment Research
27 окт 2022 г. в 21:04
Taro (TARO) delivered earnings and revenue surprises of -108.33% and 18.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?